Autism & Cord Blood: What You Need to Know
Is it possible to imagine a world free from Autism? Or practically a world where medical feats help to treat Autism back to normalcy? This wishful thinking might just translate into reality. Thanks to the research on regenerative medicines using cord blood cells. Recently, a group of researchers has been working to discover that cord blood cells might have a way to cure Autism Spectrum Disorder (ASD). It has been observed that umbilical cord blood can be instrumental in repairing the body in ASD, which further holds promise for a probable treatment.
Many Americans have been resorting to this to heal ASD in their child. The brand-new U.S clinical trial is said to be the very first to get U.S. Food and Drug Administration’s approval. Administered and managed by Dr. Michael Chez, the Director of Paediatric Neurology, Sutter Medical Center, a team of researchers sometime back had published the outcome of a Phase II Clinical Trial that looked into the effectiveness and security of autologous umbilical cord blood cells for autistic children that deployed a placebo-managed, double-blind design. In 2017, these medical researchers at Duke University also published a Phase I security trial assessing autologous umbilical cord blood in autistic children. The emphasis on cord blood cells being a potential cellular therapy accompanied by favorable findings from past clinical studies promises a brighter future in treating ASD. CBR’s initiative to explore the potential of stem cells has offered institutional funding for Stutter clinical researchers.
The Scope of Newborn Stem Cells
The emphasis on cord blood cells being effective in treating ASD stems from its innate benefits. Cells from umbilical cord blood have a set of benefits such as:
· Anti-inflammatory properties – Research has revealed that stem cells possess the capacity to normalize inflammation and migrate to the location of neurologic injury.
· Secure and available – Blood from the umbilical cord is collected easily when a baby is born and can be stored indefinitely for any future use by a close family member or the newborn donor
· Bystander effect- It is said that infused stem cells secrete factors that regenerate the body’s innate healing mechanism in and around a surrounding tissue through paracrine signaling, which is also called the bystander effect.
ASD Research Kickstarts
The first clinical research using the blood from the umbilical cord that was earlier banked from the autistic child was completed recently. The children between the ages group 2 and 6 who had ASD were researched for this study. The objective of this trial was to evaluate if blood from the umbilical cord was a secure means to use on these children and record any health improvement that might occur in a year. This children’s team was given one dose of stem cells via intravenous infusion and the effects were observed. This study paved the foundation for other advanced studies to commence in the future. It proved that cord blood cell was a secure therapy mode when transferred as an infusion. It also recognized certain symptoms that could have been influenced.
These clinical trials highlight the significance of banking an infant’s stem cells. It also offers valid reasons as to why families should spend a dear amount on cord blood banking processes. The modern-day medicine scene is at an ongoing evolution stage. And cord blood cell researchers carry on to come up with new and revolutionary treatment choices for a wide range of medical conditions that were previously said to be incurable. Clinical trials understanding the use of cord blood cells to cure Type 1 Diabetes, cerebral palsy, and stroke are already in progress. The chance of ASD being treatable with stem cells is a huge boon that the medical world can gift humanity.
